Abstract. The effect of PRL supplementation in lithium-treated rats on spermatogenesis, testicular \ g=D\ 5-3\ g=b\ -hydroxysteroid dehydrogenase and 17\g=b\-hydroxysteroid de- (8, 12, 13) , the present investigation was under¬ taken to examine the effect of PRL on lithiuminduced testicular dysfunction. A dose of 2 mg/kg was used, since it is the minimum dose that pro¬ duces toxic effects on testicular activity, whereas 1 mg/kg has no significant effect (8). Moreover, the dose of 2 mg/kg produces serum levels of lithium which are around the therapeutic range in man.
sulted in a remarkable protection of spermatogenic and steroidogenic activities of the testes, along with restoration of serum levels of FSH and testosterone. It is con- cluded that PRL can markedly protect the testicular dysfunction induced by lithium chloride treatment in rats.
Although the therapeutic usefulness of lithium for the treatment of manic depressive psychosis (1, 2) remains indisputable, there is a wide range of ad¬ verse effects on metabolic and endocrine functions following lithium treatment in psychotic patients (3) . Lithium causes clinical hypothyroidism (3) , ac¬ tivation of adrenocortical functions (4) and is a male reproductive toxicant (5) (6) (7) (8) (9) .
Unfortunately, there is an apparent paucity of information concerning the effects of lithium on the reproductive system. In this regard, it should be noted that in mature rats, lithium inhibits the plasma levels of LH, FSH, PRL and testosterone (5, 6) , but these studies, however, have not provided consistent results. Recently we have shown that lithium administration in toad (7) and in mature (8) and immature rats (9) results in inhibition of testi¬ cular steroidogenesis and spermatogenesis. Since there is a close relationship between PRL and testi¬ cular activities (10, 11) and chronic lithium treat¬ ment results in a remarkable inhibition of plasma PRL (8, 12, 13) , the present investigation was under¬ taken to examine the effect of PRL on lithiuminduced testicular dysfunction. A dose of 2 mg/kg was used, since it is the minimum dose that pro¬ duces toxic effects on testicular activity, whereas 1 mg/kg has no significant effect (8) . Moreover, the dose of 2 mg/kg produces serum levels of lithium which are around the therapeutic range in man. The duration of 21 days was selected as this is the minimum duration of lithium treatment for testi¬ cular steroidogenesis and gametogenesis to be af¬ fected (14) . Materials (15) and tubular shrinkage by the Sertoli cell correction factor (16) . The¬ oretically, the midpachytene spermatocyte (mPSc) to step 7 spermatid (7 Sd) ratio should be 1:4 as each sperma¬ tocyte after two successive reduction divisions forms four spermatids (17) . The Assay of testicular A3-3ß-hydroxysteroid dehydrogenase and 1 lß-hydroxysteroid dehydrogenase activity One testis from each animal was used for studying the activities of A°-3ß-hydroxysteroid dehydrogenase (A3-3ß-HSD) and 17ß-hydroxysteroid dehydrogenase (17ß-HSD). Testicular A5-3ß-HSD was assayed spectrophotometrically according to the procedure of Talalay (18) . The activity of 17ß-HSD was measured in UV spectrophotometer according to the procedure of Jarabak et al. (19) . One (12) .
The low serum level of PRL is also one of the causes for the diminution of serum testosterone in lith¬ ium-treated animals, as PRL potentiates the effect of LH on testicular androgen synthesis (10, 11, 27 (27, 28) . The failure of PRL to restore the serum LH levels in lithium-treated rats cannot be ex¬ plained properly, though it is consistent with a pre¬ vious report (27) . Moreover, it has been indicated that PRL affects the testicular sterodogenesis by increasing the availability of precursors for andro¬ gen biosynthesis (29) , perhaps by regulating the activity of cholesterol ester synthetase in the testes in a manner similar to that described in the ovary (30) . Beside this, PRL increases testicular activities of A5-3ß-and 17ß-HSD in hereditary dwarf mice (10, 31) as well as significantly increases serum an¬ drogen levels in hypophysectomized rats (11 (25) and the diminution of pituitary FSH secretion may be the reason for the degeneration of spermatogonia. Rüssel et al. (34) reported that FSH is required to obtain quan¬ titatively normal spermatogenesis in pubertal rats. The reduction in the number of 7Sd is probably due to the low level of testosterone, because the conversion of pachytene spermatocyte to sperma¬ tid requires testosterone (35, 36) or is indirectly af¬ fected by the lack of pituitary FSH and LH (37) . The mechanism by which PRL restores the sper¬ matogenic activity in lithium-treated rats is not de¬ finitely known, but it may be suggested that PRL exerts these effects by modulating pituitary FSH secretion as well as by stimulating testicular andro¬ gen synthesis.
In conclusion, for the first time our data provide evidence that PRL administration leads to restora¬ tion of testicular activities which are affected by lithium treatment.
